Goldman Sachs (NASDAQ: TDAC) reports 6.1% position in TDAC
Rhea-AI Filing Summary
Translational Development Acquisition Corp. disclosure: The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC jointly report shared voting and dispositive power over 1,054,120 Class A ordinary shares (CUSIP G9008W105), representing 6.1% of the class as shown on the cover page. The filing includes a Joint Filing Agreement and exhibits clarifying that the holdings are reported by Goldman Sachs reporting units and that Goldman Sachs & Co. LLC is a subsidiary of GS Group. The signature block shows the filing was executed on 05/07/2026.
Positive
- None.
Negative
- None.
Insights
Goldman Sachs reports a 6.1% position in TDAC via shared voting/dispositive power.
The schedule shows 1,054,120 shares of Class A ordinary shares (CUSIP G9008W105) tied to Goldman Sachs reporting units. The filing is a joint statement executed under a Joint Filing Agreement and includes exhibits identifying the reporting subsidiary relationships.
Ownership is reported as shared voting and dispositive power; the filing disclaims beneficial ownership for client accounts per the cited Release. Timing and cash‑flow treatment are not detailed in the excerpt; subsequent filings would state any transactions or changes.